Results

Total Results: 9,570 records

Showing results for "scenarios".

  1. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0120-fullreport.pdf
    May 01, 2018 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  2. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
    September 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  3. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-fullreport.pdf
    October 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  4. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
    November 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  5. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0120-fullreport.pdf
    May 01, 2018 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  6. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
    November 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  7. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
    September 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  8. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
    November 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  9. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0120-fullreport.pdf
    May 01, 2018 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  10. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-fullreport.pdf
    October 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  11. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0120-fullreport.pdf
    May 01, 2018 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  12. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
    September 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  13. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
    November 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  14. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-fullreport.pdf
    October 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  15. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0120-fullreport.pdf
    May 01, 2018 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  16. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
    September 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  17. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
    November 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  18. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-fullreport.pdf
    October 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  19. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
    September 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal
  20. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
    November 01, 2019 - this process was participation by a broad group of experts in the development of clinically detailed scenarios … The route to measure specification included development of relevant scenarios and issues for formal